ALB and Hypokalemia: The study revealed that patient’s serum albumin levels (≥2.82 mg/dl) at the start of L-AMB administration and history of hypokalemia prior to L-AMB administration were independent risk factors significantly contributing to the occurrence of hypokalemia (5).